Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (141-150 of 308) with videos related to

Pageof 31
Sort By:
European Journal of Clinical Pharmacology|February 24, 2007
Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interactionTom Schalekamp, Johanna H H van Geest-Daalderop, Mark H H Kramer, et al.
The American Journal of Gastroenterology|May 1, 2013
Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls: a nationwide cohort studyArief Lalmohamed, Peter Vestergaard, M Kassim Javaid, et al.
British Journal of Clinical Pharmacology|August 16, 2016
Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research DatalinkSeyed Hamidreza Mahmoudpour, Ekaterina Vitalievna Baranova, Patrick C Souverein, et al.
Pharmacy World & Science : PWS|December 16, 2004
Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?David A M C van de Vijver, Raymund A C Roos, Paul A F Jansen, et al.
BMJ Mental Health|June 20, 2024
Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitorsSem E Cohen, Damiaan A J P Denys, Taina Kristiina Mattila, et al.
Drug Safety|January 15, 2004
Failure to continue lipid-lowering drug use following the withdrawal of cerivastatinAukje K Mantel-Teeuwisse, Olaf H Klungel, Toine C G Egberts, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
Acenocoumarol stabilization is delayed in CYP2C93 carriersTom Schalekamp, Johanna H H van Geest-Daalderop, Hanneke de Vries-Goldschmeding, et al.
Journal of Clinical Epidemiology|June 19, 2019
A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelinesRafael Dal-Ré, Cristina Avendaño-Solà, Anthonius de Boer, et al.
Plos Medicine|March 26, 2013
Number of patients studied prior to approval of new medicines: a database analysisRuben G Duijnhoven, Sabine M J M Straus, June M Raine, et al.
Pharmacoeconomics|March 6, 2007
Economic evaluations of cholesterol-lowering drugs: a critical and systematic reviewPearl D Gumbs, Monique W M Verschuren, Aukje K Mantel-Teeuwisse, et al.
Pageof 31

Showing results (141-150 of 308) with videos related to

Sort By:
Pageof 31
European Journal of Clinical Pharmacology|February 24, 2007
Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interactionTom Schalekamp, Johanna H H van Geest-Daalderop, Mark H H Kramer, et al.
The American Journal of Gastroenterology|May 1, 2013
Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls: a nationwide cohort studyArief Lalmohamed, Peter Vestergaard, M Kassim Javaid, et al.
British Journal of Clinical Pharmacology|August 16, 2016
Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research DatalinkSeyed Hamidreza Mahmoudpour, Ekaterina Vitalievna Baranova, Patrick C Souverein, et al.
Pharmacy World & Science : PWS|December 16, 2004
Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?David A M C van de Vijver, Raymund A C Roos, Paul A F Jansen, et al.
BMJ Mental Health|June 20, 2024
Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitorsSem E Cohen, Damiaan A J P Denys, Taina Kristiina Mattila, et al.
Drug Safety|January 15, 2004
Failure to continue lipid-lowering drug use following the withdrawal of cerivastatinAukje K Mantel-Teeuwisse, Olaf H Klungel, Toine C G Egberts, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
Acenocoumarol stabilization is delayed in CYP2C93 carriersTom Schalekamp, Johanna H H van Geest-Daalderop, Hanneke de Vries-Goldschmeding, et al.
Journal of Clinical Epidemiology|June 19, 2019
A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelinesRafael Dal-Ré, Cristina Avendaño-Solà, Anthonius de Boer, et al.
Plos Medicine|March 26, 2013
Number of patients studied prior to approval of new medicines: a database analysisRuben G Duijnhoven, Sabine M J M Straus, June M Raine, et al.
Pharmacoeconomics|March 6, 2007
Economic evaluations of cholesterol-lowering drugs: a critical and systematic reviewPearl D Gumbs, Monique W M Verschuren, Aukje K Mantel-Teeuwisse, et al.
Pageof 31